Skip to main content

Advertisement

SpringerLink
Log in

Immune studies by the use of Multitest-Merieux in patients with kidney tumours

  • Published:
International Urology and Nephrology Aims and scope Submit manuscript

Abstract

Responsiveness to recall antigens was studied by the use of Multitest-Merieux in 20 cases of kidney tumour with and without deposits. The patients of either group, compared with the controls, had depressed scores of immunoreactivity. After surgical removal of the tumour-bearing kidney, immunoreactivity increased, regardless of the presence or absence of deposits. The number of reacting antigens also increased in every case. Lymphocyte transformationin vitro was also depressed, in comparison with the controls before surgery, but after the intervention the transformed blast cells increased in number. Multitest was found suitable for studies of delayed-type sensitivity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Brosman, S., Hausman, M., Shaks, S. J.: Studies on the immune status of patients with adenocarcinoma.J. Urol., 114, 375 (1975).

    PubMed  CAS  Google Scholar 

  2. Brosman, S., Elhilali, M., Vescera, C., Fahey, I.: Immune response in bladder cancer patients.J. Urol., 121, 162 (1979).

    PubMed  CAS  Google Scholar 

  3. Catalona, W. J., Ratliff, T. L., McCool, R.: Concanavalin A inducible suppressor cells in regional lymph nodes of cancer patients.Cancer Res., 39, 372 (1979).

    Google Scholar 

  4. Delbrück, H., Schwarze, G., Kopper, B.: Immunmonitorung mit Recell-Antigenen bei Patienten mit disseminiertem malignem Hodenteratom.Beitr. Onkol., 8, 271 (1981).

    Google Scholar 

  5. Dunzendorfer, U., Jung, K., Ohlenschläger, G.: Transferrin, C3 complement, haptoglobin, plasminogen and alfa-2-macroglobulin in patients with urogenital tumors.Eur. Urol., 6, 232 (1980).

    PubMed  CAS  Google Scholar 

  6. Flamm, J., Sagaster, P., Miksche, M.: Klinische und immunologische Untersuchungen bei Patienten mit Harnblasentumoren.Urologe, 17, 111 (1978).

    Google Scholar 

  7. Hakala, T. R., Lange, P. H., Castro, A., Ellio, A., Fraley, E. E.: Cell-mediated cytotoxicity against human transitional cell carcinoma of the genitourinary tract.Cancer, 34, 1929 (1974).

    Article  PubMed  CAS  Google Scholar 

  8. Hellström, J., Hellström, K. E., Sjögren, H. O., Warner, G. A.: Demonstration of cell-mediated immunity to human neoplasms of various histological types.Int. J. Cancer, 7, 1 (1971).

    PubMed  Google Scholar 

  9. Jonian, M., Baert, T.: Evaluation of beta-2-microglobulin as a marker for malignancy in cystic fluids, especially in renal origin. Extract from Symp. on beta-2-microglobulin in proliferative disorders.Bruxelles Abstr., 3 (1977).

  10. Kulcsár, G., Dán, P., Sallay, K., Nász, I.: Human lymphocyte transformation studies with viral antigens.Kísérl. Orvostud., 24, 69 (1972).

    Google Scholar 

  11. Lachaud, A. T., Martin-Mondiers, C.: Immune evaluation with skin test in prostatic carcinoma.Eur. Urol., 5, 117 (1979).

    Google Scholar 

  12. Martinez-Pineiro, J. A., Muntanola, P., Hidalgo, L.: Immunological evaluation in patients with urological cancer.Eur. Urol., 3, 109 (1977).

    Google Scholar 

  13. Romics, I.: Immunological aspects of urinary-tract tumours (in Hung.).Orvosképzés, 60, 45 (1985).

    Google Scholar 

  14. Romics, I.: Diagnostic and therapeutic possibilities based on the immune status of patients with tumours of bladder and prostate. Candidate's Thesis, Budapest 1985.

  15. Romics, I., Horváth, J.: Study of nonspecific lymphocyte transformation in urologic cancer patients.Int. Urol. Nephrol., 10, 261 (1978).

    Article  PubMed  CAS  Google Scholar 

  16. Romics, I., Horváth, J., Fehér, J., Csontai, Á.: Effect of levamisol on cellular and humoral immunoreactivity and recurrences in patients with bladder papilloma.Int. Urol. Nephrol., 17, 323 (1985).

    Article  PubMed  CAS  Google Scholar 

  17. Sharding, B., Mayer, W., Schwarze, G., Delbrück, H.: Delayed type skin testing in patients with benign and malignant urogenital tumors. A two-year follow-up in 143 patients. Abstr. 16. Dtsch. Krebskongress, München 1982.

  18. Schwarze, G.: Evaluation of cell-mediated immunity in renal cancer patients: influence of tumor nephrectomy and immunotherapy. I. Internat. Multitest Workshop, Lyon 1983.

  19. Stefani, S. S., Menon, M., Canning, I. R., Clark, S. S.: Cell-mediated immunity in carcinoma of the prostate.Invest. Urol., 14, 72 (1976).

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Urology, University Medical School, Budapest, Hungary

    I. Romics & D. Répássy

  2. Institute of Microbiology, University Medical School, Budapest, Hungary

    G. Kulcsár

  3. Department of Urology, University of Medicine, Bonn, FRG

    P. Brühl

Authors
  1. I. Romics
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. D. Répássy
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. G. Kulcsár
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. P. Brühl
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Romics, I., Répássy, D., Kulcsár, G. et al. Immune studies by the use of Multitest-Merieux in patients with kidney tumours. International Urology and Nephrology 19, 115–121 (1987). https://doi.org/10.1007/BF02550460

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02550460

Keywords

Search

Navigation